Tug-of-war over AI and Insurance Governance

Healthcare Innovator,

The growing tension between federal and state governments in the U.S. is reshaping how AI and insurance oversight may evolve. As reported recently, federal leaders and state regulators are in a tug-of-war over AI and insurance governance.

What This Means for Clinical Trials

When funding is volatile, operational friction is your greatest liability. If your research team is still manually reconciling data across disconnected dashboards or waiting weeks for FDA-ready documentation, you are burning capital that you may not be able to replace.

AI is being sold as the "accelerator," but without deep integration, it's just another layer of complexity. To survive the 2026 funding environment, your AI shouldn't be a "tool"—it must be your Operating System.

The Bigger Picture

Policy friction. Administrative overload. Trial delays. These aren't isolated problems. They're symptoms of systems that weren't designed for AI-native operations.

Dev Roy
CEO, Enclavia